Clip-level quality ICC
0.95 ICC
- EndpointAbdominal image-quality agreement
- Population184 patients, 200 clips
- Tested versionAI Platform 2.2
FDA-cleared profile
Exo Imaging · Ultrasound · FDA-cleared (510(k))
Authorized purpose: Provides AI-assisted cardiac, lung and abdominal quality feedback and measurements; users remain responsible for scan quality and diagnosis and must not rely solely on the software.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Provides AI-assisted cardiac, lung and abdominal quality feedback and measurements; users remain responsible for scan quality and diagnosis and must not rely solely on the software.
Evidence takeaway. Evidence from the reviewed source record: The FDA summary reports image-quality agreement in retrospective clip validation and real-time evaluation; no disease-detection sensitivity or specificity is reported.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
Packet wording: "allows users to detect, measure, and calculate relevant medical parameters of structures and function of patients with suspected disease. In addition, it provides frame and clip quality score in real-time" … "The AI modules are provided as software components to be integrated by another computer programmer into their legally marketed ultrasound imaging device.". Read from the exact FDA decision document on 2026-11-14.
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.
The exact indications for use identify the trained and qualified healthcare-professional scope.
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
0.95 ICC
K260217
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Single- or multi-frame DICOM ultrasound images from software modules integrated into compatible ultrasound devices.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-19 · FDA K260217: AI Platform 2.2 (AIP002)
Source context, not route validation: Current Exo Iris specifications describe DICOM worklist/store/send and PACS/VNA connectivity; EHR access requires Exo Works Enterprise, and worksheets/1 TB cloud storage require Connect.
Scope: Product family. Package requirements are family-level and do not establish that every AIP002 deployment includes them.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-06 · Exo Iris technical specifications
Source context, not route validation: AI modules and APIs are integrated by the ultrasound-device programmer; current hosting details were not established.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-05 · AI Platform 2.2: K260217 clearance and 510(k) summary
Source context, not route validation: Lung A/B-line presence and count; cardiac LVEF, IVC and myocardial-wall measurements; image-quality feedback for cardiac, lung and added abdominal views.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-19 · FDA K260217: AI Platform 2.2 (AIP002)
Unresolved route: Lung A/B-line presence and count; cardiac LVEF, IVC and myocardial-wall measurements; image-quality feedback for cardiac, lung and added abdominal views.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-19 · FDA K260217: AI Platform 2.2 (AIP002)
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Package requirements are family-level and do not establish that every AIP002 deployment includes them.
Vendor statements; no certificates or audit reports read. Exo's dated HITRUST/SOC 2 certification announcement is scoped to the Exo Works workflow product specifically. Applicant 'Exo Imaging' bridges to Exo (exo.inc). Exact-release scope is not established.
Vendor statement, not an attestation. The page names Exo generally and does not scope these practices to any specific product release; exact-release scope is not established. Audit reports were not read.
EHR requires Works Enterprise; worksheets and 1 TB cloud storage require Connect.
product family · checked 2026-09-06Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
No stored literature or trial candidates; empty metadata snapshots were screened. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, vendor technical page, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Bounded web search on 2026-10-26 (query: "Exo Iris reimbursement CPT coverage"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
9 sources - 3 history items
Scope: purpose, modality, anatomy, input, output, limitations, evidenceSummary, intendedUsers, clinicalUse
Scope: regulatoryIdentity, modalityContext
Scope: intendedUsers, careSetting, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: product_family_implementation
Scope: identity, clinical, implementation, evidence
Scope: security
Regulatory record
510(k)
Research record
fda record reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Clarius Mobile Health Corp.
Authorized purpose: Semi-automated measurement of left ventricular ejection fraction during cardiac ultrasound.
Ligence Uab
Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.
Ultrasight, Ltd.
Authorized purpose: PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable for this measurement.
Ligence, UAB
Authorized purpose: Automated post-processing and measurement of adult transthoracic echocardiograms to support cardiologist/sonographer review and clinical decision-making.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history